Oncolytics Biotech Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -3.87 | -100% |
| P/S |
|
0 | 33.58 | -100% |
|
|
| P/BV |
|
4.16 | 4.79 | -13.17% |
|
|
| P/FCF |
|
-6.01 | 61 | -109.85% |
|
|
| Ev/Ebitda |
|
-2.5 | -17.26 | -85.5% |
|
|
| Ev/S |
|
0 | 22.5 | -100% |
|
|
| Ev/FCF |
|
-2.94 | 69 | -104.26% |
|
|
| E/P |
|
-0.1624 | 0.0178 | -1013.71% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -1623.49 | -100% |
| ROE |
|
-100.69 | 9.61 | -1147.55% |
|
|
| ROA |
|
-71.49 | 0.3443 | -20866% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-122.6 | 15.19 | -907.29% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0127 | -3.67 | -99.65% | -0.0155 | -18.05% |
| Nеt Debt/Ebitda |
|
0.9318 | -4.06 | -122.96% |
|
|
| Debt/Ratio |
|
0.0109 | 0.199 | -94.52% |
|
|
| Debt/Equity |
|
0.0158 | 1.54 | -98.98% |
|
|
| Debt/Net Income |
|
-0.0152 | 10.34 | -100.15% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
2222.78 | 76.2 | 2817.03% | ||
| Growth impulse Ebitda in 5 years |
|
343.61 | 44.75 | 667.84% | ||
| Growth impulse Net Income in 5 years |
|
-39.08 | -15.36 | 154.43% | ||
| Growth impulse FCF in 5 years |
|
42.87 | -108.72 | -139.43% | ||
| Growth impulse EPS in 5 years |
|
-55.87 | -142.05 | -60.67% |
IP Score
3.58/10
